191 related articles for article (PubMed ID: 37315184)
21. Epigenetic inactivation of suppressors of cytokine signalling in Philadelphia-negative chronic myeloproliferative disorders.
Capello D; Deambrogi C; Rossi D; Lischetti T; Piranda D; Cerri M; Spina V; Rasi S; Gaidano G; Lunghi M
Br J Haematol; 2008 May; 141(4):504-11. PubMed ID: 18318760
[TBL] [Abstract][Full Text] [Related]
22. Alterations of SOCS1 and SOCS3 transcript levels, but not promoter methylation levels in subcutaneous adipose tissues in obese women.
Emamgholipour S; Esmaeili F; Shabani M; Hasanpour SZ; Pilehvari M; Zabihi-Mahmoudabadi H; Motevasseli M; Shanaki M
BMC Endocr Disord; 2023 Jan; 23(1):7. PubMed ID: 36609306
[TBL] [Abstract][Full Text] [Related]
23. Suppressors of cytokine signalling in ankylosing spondylitis and their associations with disease severity, acute-phase reactants and serum cytokines.
Chen CH; Chen HA; Liao HT; Liu CH; Tsai CY; Chou CT
Clin Exp Rheumatol; 2016; 34(1):100-5. PubMed ID: 26812031
[TBL] [Abstract][Full Text] [Related]
24. SOCS3 promoter hypermethylation is a favorable prognosticator and a novel indicator for G-CIMP-positive GBM patients.
Feng Y; Wang Z; Bao Z; Yan W; You G; Wang Y; Hu H; Zhang W; Zhang Q; Jiang T
PLoS One; 2014; 9(3):e91829. PubMed ID: 24633048
[TBL] [Abstract][Full Text] [Related]
25. Specific function of STAT3, SOCS1, and SOCS3 in the regulation of proliferation and survival of classical Hodgkin lymphoma cells.
Baus D; Pfitzner E
Int J Cancer; 2006 Mar; 118(6):1404-13. PubMed ID: 16206268
[TBL] [Abstract][Full Text] [Related]
26. Impaired IFN-gamma-dependent inflammatory responses in human keratinocytes overexpressing the suppressor of cytokine signaling 1.
Federici M; Giustizieri ML; Scarponi C; Girolomoni G; Albanesi C
J Immunol; 2002 Jul; 169(1):434-42. PubMed ID: 12077274
[TBL] [Abstract][Full Text] [Related]
27. Suppressor of cytokine signaling (SOCS) genes are downregulated in breast cancer.
Ghafouri-Fard S; Oskooei VK; Azari I; Taheri M
World J Surg Oncol; 2018 Nov; 16(1):226. PubMed ID: 30453988
[TBL] [Abstract][Full Text] [Related]
28. Enforced SOCS1 and SOCS3 expression attenuates Lck-mediated cellular transformation.
Cooper JC; Shi M; Chueh FY; Venkitachalam S; Yu CL
Int J Oncol; 2010 May; 36(5):1201-8. PubMed ID: 20372794
[TBL] [Abstract][Full Text] [Related]
29. Respiratory Syncytial Virus Nonstructural Proteins Upregulate SOCS1 and SOCS3 in the Different Manner from Endogenous IFN Signaling.
Zheng J; Yang P; Tang Y; Pan Z; Zhao D
J Immunol Res; 2015; 2015():738547. PubMed ID: 26557722
[TBL] [Abstract][Full Text] [Related]
30. Chronic rhinosinusitis with polyps and without polyps is associated with increased expression of suppressors of cytokine signaling 1 and 3.
Park SJ; Kim TH; Jun YJ; Lee SH; Ryu HY; Jung KJ; Jung JY; Hwang GH; Lee SH
J Allergy Clin Immunol; 2013 Mar; 131(3):772-80. PubMed ID: 23375208
[TBL] [Abstract][Full Text] [Related]
31. The suppressor of cytokine signaling (SOCS) 1 and SOCS3 but not SOCS2 proteins inhibit interferon-mediated antiviral and antiproliferative activities.
Song MM; Shuai K
J Biol Chem; 1998 Dec; 273(52):35056-62. PubMed ID: 9857039
[TBL] [Abstract][Full Text] [Related]
32. miR-19a: an effective regulator of SOCS3 and enhancer of JAK-STAT signalling.
Collins AS; McCoy CE; Lloyd AT; O'Farrelly C; Stevenson NJ
PLoS One; 2013; 8(7):e69090. PubMed ID: 23894411
[TBL] [Abstract][Full Text] [Related]
33. Intrahepatic mRNA levels of SOCS1 and SOCS3 are associated with cirrhosis but do not predict virological response to therapy in chronic hepatitis C.
Pascarella S; Clément S; Dill MT; Conzelmann S; Lagging M; Missale G; Neumann AU; Pawlotsky JM; Zeuzem S; Rubbia-Brandt L; Bochud PY; Negro F
Liver Int; 2013 Jan; 33(1):94-103. PubMed ID: 23164156
[TBL] [Abstract][Full Text] [Related]
34. Suppressors of cytokine signaling modulate JAK/STAT-mediated cell responses during atherosclerosis.
Ortiz-Muñoz G; Martin-Ventura JL; Hernandez-Vargas P; Mallavia B; Lopez-Parra V; Lopez-Franco O; Muñoz-Garcia B; Fernandez-Vizarra P; Ortega L; Egido J; Gomez-Guerrero C
Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):525-31. PubMed ID: 19164812
[TBL] [Abstract][Full Text] [Related]
35. Regulation of miR-155 affects pancreatic cancer cell invasiveness and migration by modulating the STAT3 signaling pathway through SOCS1.
Huang C; Li H; Wu W; Jiang T; Qiu Z
Oncol Rep; 2013 Sep; 30(3):1223-30. PubMed ID: 23817566
[TBL] [Abstract][Full Text] [Related]
36. Differential expression and potential role of SOCS1 and SOCS3 in Wallerian degeneration in injured peripheral nerve.
Girolami EI; Bouhy D; Haber M; Johnson H; David S
Exp Neurol; 2010 May; 223(1):173-82. PubMed ID: 19576891
[TBL] [Abstract][Full Text] [Related]
37. Pure curcumin increases the expression of SOCS1 and SOCS3 in myeloproliferative neoplasms through suppressing class I histone deacetylases.
Chen CQ; Yu K; Yan QX; Xing CY; Chen Y; Yan Z; Shi YF; Zhao KW; Gao SM
Carcinogenesis; 2013 Jul; 34(7):1442-9. PubMed ID: 23430957
[TBL] [Abstract][Full Text] [Related]
38. Production of interferon α and β, pro-inflammatory cytokines and the expression of suppressor of cytokine signaling (SOCS) in obese subjects infected with influenza A/H1N1.
Terán-Cabanillas E; Montalvo-Corral M; Silva-Campa E; Caire-Juvera G; Moya-Camarena SY; Hernández J
Clin Nutr; 2014 Oct; 33(5):922-6. PubMed ID: 24182768
[TBL] [Abstract][Full Text] [Related]
39. Suppressor of cytokine signaling 1 inhibits IL-10-mediated immune responses.
Ding Y; Chen D; Tarcsafalvi A; Su R; Qin L; Bromberg JS
J Immunol; 2003 Feb; 170(3):1383-91. PubMed ID: 12538698
[TBL] [Abstract][Full Text] [Related]
40. Expression of SOCS1 and SOCS3 genes is differentially regulated in breast cancer cells in response to proinflammatory cytokine and growth factor signals.
Evans MK; Yu CR; Lohani A; Mahdi RM; Liu X; Trzeciak AR; Egwuagu CE
Oncogene; 2007 Mar; 26(13):1941-8. PubMed ID: 17001312
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
